Speaking of prognosis, studies have established prognostic models in cervical cancer using m6A/m5C/m1A-related genes to predict survival time and its correlation with immune cell infiltration, and found associations with sensitivity to anti-CTLA-4 immunotherapy drugs (66). This evidence concerns the gene CTLA4 and cervical carcinoma.